Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation
13th Nov 2006, 21:51 GMT
Spectrum Filed ANDA With Paragraph IV Certification for Sumatriptan Injection in October 2004 and Received Tentative Approval From the FDA in October 2006
Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation related news:
- Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation Spectrum Filed ANDA With Paragraph IV Certification for Sumatriptan Injection in October 2004 and Received Tentative Approval From the FDA in October 2006 — mysan.de - Lifestyle News
- Spectrum Pharmaceuticals Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation — PR Newswire: All Releases
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex Injection Patent Litigation — Partnerships/ Joint Ventures News from StratCenter.com
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation — PR Newswire: All Releases
- Spectrum Pharmaceuticals settles with GlaxoSmithKline — bizjournals.com Health Care:Pharmaceuticals headlines
- Spectrum Says It Reaches Glaxo Settlement — Pharmaceuticals News from StratCenter.com
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline — bizjournals.com Health Care:Pharmaceuticals headlines
- Spectrum settles patent dispute with GSK — Pharmaceutical Business Review Latest News
- Spectrum Pharmaceuticals verkündet Vergleichsvereinbarung mit GlaxoSmithKline im Patentstreit um Imitrex(R)-Injektion — Presseportal
- Spectrum Pharmaceuticals gets $5M milestone payment — Latest news from Los Angeles Business from bizjournals
Latest news from Government/ Industry Regulation News from StratCenter.com:
- PLC Systems to Show RenalGuard at Medica 2006
- National Public Health Summit Targets Cervical Cancer Elimination
- MediPurpose Announces Exclusive Distribution Agreement for Sangofer Blood Separation Product
- Portrait PSR3 by Rhytec named in TIME Magazine's 2006 Skin Technology Story
- Pharsight Invited to Present on Model-Based Drug Development rd Annual Australian Health and Medical Research Congress
- Spectrum Pharmaceuticals Announces Presentation of Ozarelix Data at the Congress of the Societe Internationale d'Urologie
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ
- Sector Election Boosts Stem Cells
- AUDIO From Medialink and AARP: Voters' Call for Change Signals New Directions for Health Care
- Schering-Plough CEO Calls on New Congress to 'Do What Is Right' for the Patient, Calls for 'Scorecards' to Rate Managed Care Performance